Paritaprevir (b)

CAS No. 1221573-85-8

Paritaprevir (b)( —— )

Catalog No. M10838 CAS No. 1221573-85-8

Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 83 In Stock
5MG 41 In Stock
10MG 55 In Stock
25MG 87 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Paritaprevir (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor.
  • Description
    Paritaprevir is a Hepatitis C Virus NS3/4A Protease Inhibitor. The mechanism of action of paritaprevir is as a HCV NS3/4A Protease Inhibitor, and Organic Anion Transporting Polypeptide 1B1 Inhibitor, and Organic Anion Transporting Polypeptide 1B3 Inhibitor, and Breast Y Resistance Protein Inhibitor, and UGT1A1 Inhibitor, and P-Glycoprotein Inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    HCV NS3/4A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1221573-85-8
  • Formula Weight
    765.89
  • Molecular Formula
    C40H43N7O7S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    Cc1ncc(nc1)C(=O)N[C@H]5CCCCCC=C[C@@H]8C[C@]8(NC(=O)[C@@H]6C[C@@H](Oc3nc4ccccc4c2ccccc23)CN6C5=O)C(=O)NS(=O)(=O)C7CC7
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Todt D, et al. J Antimicrob Chemother. 2017 Jan 18.
molnova catalog
related products
  • Odalasvir

    Odalasvir (ACH-3102, JNJ-64289901) is a potent, second-generation HCV NS5A inhibitor.

  • RO8191

    RO8191 (CDM-3008), an imidazonaphthyridine compound, is an agonist of interferon (IFN) receptor.

  • Velpatasvir

    Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.